img

Global Argatroban Injection Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Argatroban Injection Market Insights, Forecast to 2034

Global Argatroban Injection market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2024 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Argatroban Injection industry is evaluated to reach US$ million in 2034. The CAGR will be % during 2023 to 2034.
Globally, Argatroban Injection key manufacturers include Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd., Dalian Fangu Pharmaceutical Co., Ltd., Par Pharmaceutical, Pfizer, Fresenius Kabi, Hikma Pharmaceuticals, Caplin Steriles, Natco Pharma Ltd and Eagle Pharmaceuticals, etc. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd., Dalian Fangu Pharmaceutical Co., Ltd., Par Pharmaceutical are top 3 players and held % sales share in total in 2024.
When considering the consumption regions, % volume of Argatroban Injection were sold to North America, Europe and Asia Pacific in 2024. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2034 and the sales share will be % in 2034. Moreover, China, plays a key role in the whole Argatroban Injection market and estimated to attract more attentions from industry insiders and investors.
Argatroban Injection can be divided into Generic Drugs and Original Drugs, etc. Generic Drugs is the mainstream product in the market, accounting for % sales share globally in 2024 and the proportion will be % in 2034.
Argatroban Injection is widely used in various fields, such as Thromboangiitis Obliterans, Obliterative Arteriosclerosis and Other,, etc. Thromboangiitis Obliterans provides greatest supports to the Argatroban Injection industry development. In 2024, global % sales of Argatroban Injection went into Thromboangiitis Obliterans filed and the proportion will reach to % in 2034.
Report Covers
This report presents an overview of global Argatroban Injection market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global Argatroban Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2034 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
Dalian Fangu Pharmaceutical Co., Ltd.
Par Pharmaceutical
Pfizer
Fresenius Kabi
Hikma Pharmaceuticals
Caplin Steriles
Natco Pharma Ltd
Eagle Pharmaceuticals
Nichi-Iko Co., Ltd.
Segment by Type
Generic Drugs
Original Drugs

Segment by Application


Thromboangiitis Obliterans
Obliterative Arteriosclerosis
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2034
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Argatroban Injection plant distribution, commercial date of Argatroban Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2034 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2034 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2034 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2034 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2034 in China. Product sales and revenue analysis of China from 2018 to 2034
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Argatroban Injection introduction, etc. Argatroban Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Argatroban Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Argatroban Injection Product Introduction
1.2 Market by Type
1.2.1 Global Argatroban Injection Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Generic Drugs
1.2.3 Original Drugs
1.3 Market by Application
1.3.1 Global Argatroban Injection Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Thromboangiitis Obliterans
1.3.3 Obliterative Arteriosclerosis
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Argatroban Injection Sales Estimates and Forecasts 2018-2034
2.2 Global Argatroban Injection Revenue by Region
2.2.1 Global Argatroban Injection Revenue by Region: 2018 VS 2024 VS 2034
2.2.2 Global Argatroban Injection Revenue by Region (2018-2023)
2.2.3 Global Argatroban Injection Revenue by Region (2024-2034)
2.2.4 Global Argatroban Injection Revenue Market Share by Region (2018-2034)
2.3 Global Argatroban Injection Sales Estimates and Forecasts 2018-2034
2.4 Global Argatroban Injection Sales by Region
2.4.1 Global Argatroban Injection Sales by Region: 2018 VS 2024 VS 2034
2.4.2 Global Argatroban Injection Sales by Region (2018-2023)
2.4.3 Global Argatroban Injection Sales by Region (2024-2034)
2.4.4 Global Argatroban Injection Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Argatroban Injection Sales by Manufacturers
3.1.1 Global Argatroban Injection Sales by Manufacturers (2018-2023)
3.1.2 Global Argatroban Injection Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Argatroban Injection in 2024
3.2 Global Argatroban Injection Revenue by Manufacturers
3.2.1 Global Argatroban Injection Revenue by Manufacturers (2018-2023)
3.2.2 Global Argatroban Injection Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Argatroban Injection Revenue in 2024
3.3 Global Key Players of Argatroban Injection, Industry Ranking, 2021 VS 2024 VS 2023
3.4 Global Argatroban Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Argatroban Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Argatroban Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Argatroban Injection, Product Offered and Application
3.8 Global Key Manufacturers of Argatroban Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Argatroban Injection Sales by Type
4.1.1 Global Argatroban Injection Historical Sales by Type (2018-2023)
4.1.2 Global Argatroban Injection Forecasted Sales by Type (2024-2034)
4.1.3 Global Argatroban Injection Sales Market Share by Type (2018-2034)
4.2 Global Argatroban Injection Revenue by Type
4.2.1 Global Argatroban Injection Historical Revenue by Type (2018-2023)
4.2.2 Global Argatroban Injection Forecasted Revenue by Type (2024-2034)
4.2.3 Global Argatroban Injection Revenue Market Share by Type (2018-2034)
4.3 Global Argatroban Injection Price by Type
4.3.1 Global Argatroban Injection Price by Type (2018-2023)
4.3.2 Global Argatroban Injection Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Argatroban Injection Sales by Application
5.1.1 Global Argatroban Injection Historical Sales by Application (2018-2023)
5.1.2 Global Argatroban Injection Forecasted Sales by Application (2024-2034)
5.1.3 Global Argatroban Injection Sales Market Share by Application (2018-2034)
5.2 Global Argatroban Injection Revenue by Application
5.2.1 Global Argatroban Injection Historical Revenue by Application (2018-2023)
5.2.2 Global Argatroban Injection Forecasted Revenue by Application (2024-2034)
5.2.3 Global Argatroban Injection Revenue Market Share by Application (2018-2034)
5.3 Global Argatroban Injection Price by Application
5.3.1 Global Argatroban Injection Price by Application (2018-2023)
5.3.2 Global Argatroban Injection Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Argatroban Injection Market Size by Type
6.1.1 US & Canada Argatroban Injection Sales by Type (2018-2034)
6.1.2 US & Canada Argatroban Injection Revenue by Type (2018-2034)
6.2 US & Canada Argatroban Injection Market Size by Application
6.2.1 US & Canada Argatroban Injection Sales by Application (2018-2034)
6.2.2 US & Canada Argatroban Injection Revenue by Application (2018-2034)
6.3 US & Canada Argatroban Injection Market Size by Country
6.3.1 US & Canada Argatroban Injection Revenue by Country: 2018 VS 2024 VS 2034
6.3.2 US & Canada Argatroban Injection Sales by Country (2018-2034)
6.3.3 US & Canada Argatroban Injection Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Argatroban Injection Market Size by Type
7.1.1 Europe Argatroban Injection Sales by Type (2018-2034)
7.1.2 Europe Argatroban Injection Revenue by Type (2018-2034)
7.2 Europe Argatroban Injection Market Size by Application
7.2.1 Europe Argatroban Injection Sales by Application (2018-2034)
7.2.2 Europe Argatroban Injection Revenue by Application (2018-2034)
7.3 Europe Argatroban Injection Market Size by Country
7.3.1 Europe Argatroban Injection Revenue by Country: 2018 VS 2024 VS 2034
7.3.2 Europe Argatroban Injection Sales by Country (2018-2034)
7.3.3 Europe Argatroban Injection Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Argatroban Injection Market Size
8.1.1 China Argatroban Injection Sales (2018-2034)
8.1.2 China Argatroban Injection Revenue (2018-2034)
8.2 China Argatroban Injection Market Size by Application
8.2.1 China Argatroban Injection Sales by Application (2018-2034)
8.2.2 China Argatroban Injection Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Argatroban Injection Market Size by Type
9.1.1 Asia Argatroban Injection Sales by Type (2018-2034)
9.1.2 Asia Argatroban Injection Revenue by Type (2018-2034)
9.2 Asia Argatroban Injection Market Size by Application
9.2.1 Asia Argatroban Injection Sales by Application (2018-2034)
9.2.2 Asia Argatroban Injection Revenue by Application (2018-2034)
9.3 Asia Argatroban Injection Sales by Region
9.3.1 Asia Argatroban Injection Revenue by Region: 2018 VS 2024 VS 2034
9.3.2 Asia Argatroban Injection Revenue by Region (2018-2034)
9.3.3 Asia Argatroban Injection Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Argatroban Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Argatroban Injection Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Argatroban Injection Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Argatroban Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Argatroban Injection Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Argatroban Injection Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Argatroban Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Argatroban Injection Revenue by Country: 2018 VS 2024 VS 2034
10.3.2 Middle East, Africa and Latin America Argatroban Injection Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Argatroban Injection Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
11.1.1 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
11.1.2 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Overview
11.1.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Argatroban Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Developments
11.2 Dalian Fangu Pharmaceutical Co., Ltd.
11.2.1 Dalian Fangu Pharmaceutical Co., Ltd. Company Information
11.2.2 Dalian Fangu Pharmaceutical Co., Ltd. Overview
11.2.3 Dalian Fangu Pharmaceutical Co., Ltd. Argatroban Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Dalian Fangu Pharmaceutical Co., Ltd. Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Dalian Fangu Pharmaceutical Co., Ltd. Recent Developments
11.3 Par Pharmaceutical
11.3.1 Par Pharmaceutical Company Information
11.3.2 Par Pharmaceutical Overview
11.3.3 Par Pharmaceutical Argatroban Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Par Pharmaceutical Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Par Pharmaceutical Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Argatroban Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Pfizer Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Fresenius Kabi
11.5.1 Fresenius Kabi Company Information
11.5.2 Fresenius Kabi Overview
11.5.3 Fresenius Kabi Argatroban Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Fresenius Kabi Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Fresenius Kabi Recent Developments
11.6 Hikma Pharmaceuticals
11.6.1 Hikma Pharmaceuticals Company Information
11.6.2 Hikma Pharmaceuticals Overview
11.6.3 Hikma Pharmaceuticals Argatroban Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Hikma Pharmaceuticals Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hikma Pharmaceuticals Recent Developments
11.7 Caplin Steriles
11.7.1 Caplin Steriles Company Information
11.7.2 Caplin Steriles Overview
11.7.3 Caplin Steriles Argatroban Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Caplin Steriles Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Caplin Steriles Recent Developments
11.8 Natco Pharma Ltd
11.8.1 Natco Pharma Ltd Company Information
11.8.2 Natco Pharma Ltd Overview
11.8.3 Natco Pharma Ltd Argatroban Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Natco Pharma Ltd Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Natco Pharma Ltd Recent Developments
11.9 Eagle Pharmaceuticals
11.9.1 Eagle Pharmaceuticals Company Information
11.9.2 Eagle Pharmaceuticals Overview
11.9.3 Eagle Pharmaceuticals Argatroban Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Eagle Pharmaceuticals Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eagle Pharmaceuticals Recent Developments
11.10 Nichi-Iko Co., Ltd.
11.10.1 Nichi-Iko Co., Ltd. Company Information
11.10.2 Nichi-Iko Co., Ltd. Overview
11.10.3 Nichi-Iko Co., Ltd. Argatroban Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Nichi-Iko Co., Ltd. Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nichi-Iko Co., Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Argatroban Injection Industry Chain Analysis
12.2 Argatroban Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Argatroban Injection Production Mode & Process
12.4 Argatroban Injection Sales and Marketing
12.4.1 Argatroban Injection Sales Channels
12.4.2 Argatroban Injection Distributors
12.5 Argatroban Injection Customers
13 Market Dynamics
13.1 Argatroban Injection Industry Trends
13.2 Argatroban Injection Market Drivers
13.3 Argatroban Injection Market Challenges
13.4 Argatroban Injection Market Restraints
14 Key Findings in The Global Argatroban Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Argatroban Injection Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Generic Drugs
Table 3. Major Manufacturers of Original Drugs
Table 4. Global Argatroban Injection Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Argatroban Injection Revenue Grow Rate (CAGR) by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Argatroban Injection Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Argatroban Injection Revenue by Region (2024-2034) & (US$ Million)
Table 8. Global Argatroban Injection Revenue Market Share by Region (2018-2023)
Table 9. Global Argatroban Injection Revenue Market Share by Region (2024-2034)
Table 10. Global Argatroban Injection Sales Grow Rate (CAGR) by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 11. Global Argatroban Injection Sales by Region (2018-2023) & (K Units)
Table 12. Global Argatroban Injection Sales by Region (2024-2034) & (K Units)
Table 13. Global Argatroban Injection Sales Market Share by Region (2018-2023)
Table 14. Global Argatroban Injection Sales Market Share by Region (2024-2034)
Table 15. Global Argatroban Injection Sales by Manufacturers (2018-2023) & (K Units)
Table 16. Global Argatroban Injection Sales Share by Manufacturers (2018-2023)
Table 17. Global Argatroban Injection Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Argatroban Injection Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Argatroban Injection, Industry Ranking, 2021 VS 2024 VS 2023
Table 20. Argatroban Injection Price by Manufacturers 2018-2023 (US$/Unit)
Table 21. Global Argatroban Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Argatroban Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Argatroban Injection as of 2024)
Table 23. Global Key Manufacturers of Argatroban Injection, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Argatroban Injection, Product Offered and Application
Table 25. Global Key Manufacturers of Argatroban Injection, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Argatroban Injection Sales by Type (2018-2023) & (K Units)
Table 28. Global Argatroban Injection Sales by Type (2024-2034) & (K Units)
Table 29. Global Argatroban Injection Sales Share by Type (2018-2023)
Table 30. Global Argatroban Injection Sales Share by Type (2024-2034)
Table 31. Global Argatroban Injection Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Argatroban Injection Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Argatroban Injection Revenue Share by Type (2018-2023)
Table 34. Global Argatroban Injection Revenue Share by Type (2024-2034)
Table 35. Argatroban Injection Price by Type (2018-2023) & (US$/Unit)
Table 36. Global Argatroban Injection Price Forecast by Type (2024-2034) & (US$/Unit)
Table 37. Global Argatroban Injection Sales by Application (2018-2023) & (K Units)
Table 38. Global Argatroban Injection Sales by Application (2024-2034) & (K Units)
Table 39. Global Argatroban Injection Sales Share by Application (2018-2023)
Table 40. Global Argatroban Injection Sales Share by Application (2024-2034)
Table 41. Global Argatroban Injection Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Argatroban Injection Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Argatroban Injection Revenue Share by Application (2018-2023)
Table 44. Global Argatroban Injection Revenue Share by Application (2024-2034)
Table 45. Argatroban Injection Price by Application (2018-2023) & (US$/Unit)
Table 46. Global Argatroban Injection Price Forecast by Application (2024-2034) & (US$/Unit)
Table 47. US & Canada Argatroban Injection Sales by Type (2018-2023) & (K Units)
Table 48. US & Canada Argatroban Injection Sales by Type (2024-2034) & (K Units)
Table 49. US & Canada Argatroban Injection Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Argatroban Injection Revenue by Type (2024-2034) & (US$ Million)
Table 51. US & Canada Argatroban Injection Sales by Application (2018-2023) & (K Units)
Table 52. US & Canada Argatroban Injection Sales by Application (2024-2034) & (K Units)
Table 53. US & Canada Argatroban Injection Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Argatroban Injection Revenue by Application (2024-2034) & (US$ Million)
Table 55. US & Canada Argatroban Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 56. US & Canada Argatroban Injection Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Argatroban Injection Revenue by Country (2024-2034) & (US$ Million)
Table 58. US & Canada Argatroban Injection Sales by Country (2018-2023) & (K Units)
Table 59. US & Canada Argatroban Injection Sales by Country (2024-2034) & (K Units)
Table 60. Europe Argatroban Injection Sales by Type (2018-2023) & (K Units)
Table 61. Europe Argatroban Injection Sales by Type (2024-2034) & (K Units)
Table 62. Europe Argatroban Injection Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Argatroban Injection Revenue by Type (2024-2034) & (US$ Million)
Table 64. Europe Argatroban Injection Sales by Application (2018-2023) & (K Units)
Table 65. Europe Argatroban Injection Sales by Application (2024-2034) & (K Units)
Table 66. Europe Argatroban Injection Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Argatroban Injection Revenue by Application (2024-2034) & (US$ Million)
Table 68. Europe Argatroban Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 69. Europe Argatroban Injection Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Argatroban Injection Revenue by Country (2024-2034) & (US$ Million)
Table 71. Europe Argatroban Injection Sales by Country (2018-2023) & (K Units)
Table 72. Europe Argatroban Injection Sales by Country (2024-2034) & (K Units)
Table 73. China Argatroban Injection Sales by Type (2018-2023) & (K Units)
Table 74. China Argatroban Injection Sales by Type (2024-2034) & (K Units)
Table 75. China Argatroban Injection Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Argatroban Injection Revenue by Type (2024-2034) & (US$ Million)
Table 77. China Argatroban Injection Sales by Application (2018-2023) & (K Units)
Table 78. China Argatroban Injection Sales by Application (2024-2034) & (K Units)
Table 79. China Argatroban Injection Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Argatroban Injection Revenue by Application (2024-2034) & (US$ Million)
Table 81. Asia Argatroban Injection Sales by Type (2018-2023) & (K Units)
Table 82. Asia Argatroban Injection Sales by Type (2024-2034) & (K Units)
Table 83. Asia Argatroban Injection Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Argatroban Injection Revenue by Type (2024-2034) & (US$ Million)
Table 85. Asia Argatroban Injection Sales by Application (2018-2023) & (K Units)
Table 86. Asia Argatroban Injection Sales by Application (2024-2034) & (K Units)
Table 87. Asia Argatroban Injection Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Argatroban Injection Revenue by Application (2024-2034) & (US$ Million)
Table 89. Asia Argatroban Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 90. Asia Argatroban Injection Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Argatroban Injection Revenue by Region (2024-2034) & (US$ Million)
Table 92. Asia Argatroban Injection Sales by Region (2018-2023) & (K Units)
Table 93. Asia Argatroban Injection Sales by Region (2024-2034) & (K Units)
Table 94. Middle East, Africa and Latin America Argatroban Injection Sales by Type (2018-2023) & (K Units)
Table 95. Middle East, Africa and Latin America Argatroban Injection Sales by Type (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America Argatroban Injection Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Argatroban Injection Revenue by Type (2024-2034) & (US$ Million)
Table 98. Middle East, Africa and Latin America Argatroban Injection Sales by Application (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Argatroban Injection Sales by Application (2024-2034) & (K Units)
Table 100. Middle East, Africa and Latin America Argatroban Injection Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Argatroban Injection Revenue by Application (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America Argatroban Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 103. Middle East, Africa and Latin America Argatroban Injection Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Argatroban Injection Revenue by Country (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Argatroban Injection Sales by Country (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Argatroban Injection Sales by Country (2024-2034) & (K Units)
Table 107. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
Table 108. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Description and Major Businesses
Table 109. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Argatroban Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Developments
Table 112. Dalian Fangu Pharmaceutical Co., Ltd. Company Information
Table 113. Dalian Fangu Pharmaceutical Co., Ltd. Description and Major Businesses
Table 114. Dalian Fangu Pharmaceutical Co., Ltd. Argatroban Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Dalian Fangu Pharmaceutical Co., Ltd. Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Dalian Fangu Pharmaceutical Co., Ltd. Recent Developments
Table 117. Par Pharmaceutical Company Information
Table 118. Par Pharmaceutical Description and Major Businesses
Table 119. Par Pharmaceutical Argatroban Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Par Pharmaceutical Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Par Pharmaceutical Recent Developments
Table 122. Pfizer Company Information
Table 123. Pfizer Description and Major Businesses
Table 124. Pfizer Argatroban Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Pfizer Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Pfizer Recent Developments
Table 127. Fresenius Kabi Company Information
Table 128. Fresenius Kabi Description and Major Businesses
Table 129. Fresenius Kabi Argatroban Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Fresenius Kabi Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Fresenius Kabi Recent Developments
Table 132. Hikma Pharmaceuticals Company Information
Table 133. Hikma Pharmaceuticals Description and Major Businesses
Table 134. Hikma Pharmaceuticals Argatroban Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Hikma Pharmaceuticals Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Hikma Pharmaceuticals Recent Developments
Table 137. Caplin Steriles Company Information
Table 138. Caplin Steriles Description and Major Businesses
Table 139. Caplin Steriles Argatroban Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. Caplin Steriles Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Caplin Steriles Recent Developments
Table 142. Natco Pharma Ltd Company Information
Table 143. Natco Pharma Ltd Description and Major Businesses
Table 144. Natco Pharma Ltd Argatroban Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 145. Natco Pharma Ltd Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Natco Pharma Ltd Recent Developments
Table 147. Eagle Pharmaceuticals Company Information
Table 148. Eagle Pharmaceuticals Description and Major Businesses
Table 149. Eagle Pharmaceuticals Argatroban Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 150. Eagle Pharmaceuticals Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Eagle Pharmaceuticals Recent Developments
Table 152. Nichi-Iko Co., Ltd. Company Information
Table 153. Nichi-Iko Co., Ltd. Description and Major Businesses
Table 154. Nichi-Iko Co., Ltd. Argatroban Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 155. Nichi-Iko Co., Ltd. Argatroban Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Nichi-Iko Co., Ltd. Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Argatroban Injection Distributors List
Table 160. Argatroban Injection Customers List
Table 161. Argatroban Injection Market Trends
Table 162. Argatroban Injection Market Drivers
Table 163. Argatroban Injection Market Challenges
Table 164. Argatroban Injection Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Argatroban Injection Product Picture
Figure 2. Global Argatroban Injection Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Argatroban Injection Market Share by Type in 2024 & 2034
Figure 4. Generic Drugs Product Picture
Figure 5. Original Drugs Product Picture
Figure 6. Global Argatroban Injection Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Argatroban Injection Market Share by Application in 2024 & 2034
Figure 8. Thromboangiitis Obliterans
Figure 9. Obliterative Arteriosclerosis
Figure 10. Other
Figure 11. Argatroban Injection Report Years Considered
Figure 12. Global Argatroban Injection Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Argatroban Injection Revenue 2018-2034 (US$ Million)
Figure 14. Global Argatroban Injection Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 15. Global Argatroban Injection Revenue Market Share by Region (2018-2034)
Figure 16. Global Argatroban Injection Sales 2018-2034 ((K Units)
Figure 17. Global Argatroban Injection Sales Market Share by Region (2018-2034)
Figure 18. US & Canada Argatroban Injection Sales YoY (2018-2034) & (K Units)
Figure 19. US & Canada Argatroban Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Argatroban Injection Sales YoY (2018-2034) & (K Units)
Figure 21. Europe Argatroban Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Argatroban Injection Sales YoY (2018-2034) & (K Units)
Figure 23. China Argatroban Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Asia (excluding China) Argatroban Injection Sales YoY (2018-2034) & (K Units)
Figure 25. Asia (excluding China) Argatroban Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Argatroban Injection Sales YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Argatroban Injection Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Argatroban Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
Figure 29. The Top 5 and 10 Largest Manufacturers of Argatroban Injection in the World: Market Share by Argatroban Injection Revenue in 2024
Figure 30. Global Argatroban Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 31. Global Argatroban Injection Sales Market Share by Type (2018-2034)
Figure 32. Global Argatroban Injection Revenue Market Share by Type (2018-2034)
Figure 33. Global Argatroban Injection Sales Market Share by Application (2018-2034)
Figure 34. Global Argatroban Injection Revenue Market Share by Application (2018-2034)
Figure 35. US & Canada Argatroban Injection Sales Market Share by Type (2018-2034)
Figure 36. US & Canada Argatroban Injection Revenue Market Share by Type (2018-2034)
Figure 37. US & Canada Argatroban Injection Sales Market Share by Application (2018-2034)
Figure 38. US & Canada Argatroban Injection Revenue Market Share by Application (2018-2034)
Figure 39. US & Canada Argatroban Injection Revenue Share by Country (2018-2034)
Figure 40. US & Canada Argatroban Injection Sales Share by Country (2018-2034)
Figure 41. U.S. Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 42. Canada Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 43. Europe Argatroban Injection Sales Market Share by Type (2018-2034)
Figure 44. Europe Argatroban Injection Revenue Market Share by Type (2018-2034)
Figure 45. Europe Argatroban Injection Sales Market Share by Application (2018-2034)
Figure 46. Europe Argatroban Injection Revenue Market Share by Application (2018-2034)
Figure 47. Europe Argatroban Injection Revenue Share by Country (2018-2034)
Figure 48. Europe Argatroban Injection Sales Share by Country (2018-2034)
Figure 49. Germany Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 50. France Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 51. U.K. Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 52. Italy Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 53. Russia Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 54. China Argatroban Injection Sales Market Share by Type (2018-2034)
Figure 55. China Argatroban Injection Revenue Market Share by Type (2018-2034)
Figure 56. China Argatroban Injection Sales Market Share by Application (2018-2034)
Figure 57. China Argatroban Injection Revenue Market Share by Application (2018-2034)
Figure 58. Asia Argatroban Injection Sales Market Share by Type (2018-2034)
Figure 59. Asia Argatroban Injection Revenue Market Share by Type (2018-2034)
Figure 60. Asia Argatroban Injection Sales Market Share by Application (2018-2034)
Figure 61. Asia Argatroban Injection Revenue Market Share by Application (2018-2034)
Figure 62. Asia Argatroban Injection Revenue Share by Region (2018-2034)
Figure 63. Asia Argatroban Injection Sales Share by Region (2018-2034)
Figure 64. Japan Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 65. South Korea Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 66. China Taiwan Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 67. Southeast Asia Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 68. India Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Argatroban Injection Sales Market Share by Type (2018-2034)
Figure 70. Middle East, Africa and Latin America Argatroban Injection Revenue Market Share by Type (2018-2034)
Figure 71. Middle East, Africa and Latin America Argatroban Injection Sales Market Share by Application (2018-2034)
Figure 72. Middle East, Africa and Latin America Argatroban Injection Revenue Market Share by Application (2018-2034)
Figure 73. Middle East, Africa and Latin America Argatroban Injection Revenue Share by Country (2018-2034)
Figure 74. Middle East, Africa and Latin America Argatroban Injection Sales Share by Country (2018-2034)
Figure 75. Brazil Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 76. Mexico Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 77. Turkey Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 78. Israel Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 79. GCC Countries Argatroban Injection Revenue (2018-2034) & (US$ Million)
Figure 80. Argatroban Injection Value Chain
Figure 81. Argatroban Injection Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries